A clinical trial provides encouraging results on ivermectin for reducing mild COVID-19
2021-01-19
(Press-News.org) A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission. The study, which is part of the SAINT project and has been led by the University of Navarra Clinic and the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation, warrants further exploration in larger clinical trials. The findings of the pilot study have been published in EClinicalMedicine, a clinical journal published by The Lancet.
We already have two approved COVID-19 vaccines in the European Union, but immunising enough people worldwide to stop viral spread will require at least two years. Meanwhile, finding drugs that can treat or prevent infections remains a priority. "Many efforts are focusing on developing treatments for COVID-19, but few are addressing how to reduce viral transmission," affirms study coordinator Carlos Chaccour, researcher at ISGlobal and physician at the University of Navarra Clinic.
In this pilot study performed with patients from the Clinic and in facilities of the University of Navarra, Chaccour and his team evaluated whether the maximal dose of ivermectin recommended in Europe could have an impact on viral transmission when administered within the first days after symptom onset.
Ivermectin is an antiparasitic drug that has been shown to reduce SARS-CoV-2 replication in vitro (in cell lines), albeit at concentrations that exceed those recommended for human use. This, together with preliminary results from a trial in humans which used data of dubious origin and was never peer-reviewed, prompted the use of ivermectin in many Latin-American countries despite the lack of reliable evidence on its efficacy in treating or preventing infection.
The research team gave one single dose of ivermectin or placebo to 24 patients with confirmed infection and mild symptoms, within the first 72 hours after the first symptoms started. Nasal swabs and blood samples were taken at the moment of enrolment and 1, 2 and/or 3 weeks after treatment.
Seven days after treatments, no difference was observed in the percentage of PCR-positive patients (100% of patients were positive in both groups). However, the mean viral load in the ivermectin-treated group was lower (around 3x lower at 4 days and up to 18x lower at 7 days post-treatment), although the difference was not statistically significant. Treated patients also showed a reduced duration of certain symptoms (of 50% for loss of smell and taste and of 30% for cough). All patients developed virus-specific IgG but, again, the mean level of antibodies in the treated group was lower than in the placebo group. "This could be the result of a lower viral load in these patients," explains Chaccour.
The fact that there was no effect on duration of symptoms or makers associated with inflammation suggests that ivermectin may act through mechanisms that do not involve a possible anti-inflammatory effect. The authors believe it could be interfering with viral entry in the cells, as suggested by another study performed in hamsters at the Pasteur Institute.
"Our findings are in line with those from recent assays conducted in Bangladesh and Argentina," says Chaccour. "Although our study is small and it is too early to draw conclusions, the trends observed in viral loads, symptom duration and antibody levels are encouraging and warrant further exploration in larger clinical trials with a higher diversity of patients," he adds.
INFORMATION:
Reference
Chaccour C, Casellas A, Blanco-Di Matteo A, et al. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine. 2021. DOI: 10.1016/j.eclinm.2020.100720
About ISGlobal
The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between the "la Caixa" Foundation and academic and government institutions to contribute to the efforts undertaken by the international community to address the challenges in global health. ISGlobal is a consolidated hub of excellence in research that has grown out of work first started in the world of health care by the Hospital Clínic and the Parc de Salut MAR and in the academic sphere by the University of Barcelona and Pompeu Fabra University. The pivotal mechanism of its work model is the transfer of knowledge generated by scientific research to practice, a task undertaken by the institute's Education and Policy and Global Development departments. ISGlobal has been named a Severo Ochoa Centre of Excellence and is a member of the CERCA system of the Generalitat de Catalunya.
About the Clínica Universidad de Navarra
With over 2,800 professionals working exclusively at its headquarters in Pamplona and Madrid, the Clínica Universidad de Navarra is a leading research hospital in Spain in the sector of personalised medicine. A recognised institution for both its teaching and research work, the prestige of its professionals, and its trajectory in the diagnosis and treatment of highly complex pathologies, the Clínica Universidad de Navarra is a high resolution hospital characterised by its diagnostic speed owing to its multidisciplinary work and the acquisition of the latest technology to offer care in 46 different medical and surgical specialties.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-19
A new study from North Carolina State University shows that the inflammation caused by Clostridioides difficile (C. diff) infection gives the pathogen a two-fold advantage: by both creating an inhospitable environment for competing bacteria and providing nutrients that enable C. diff to thrive.
C. diff is a bacterium that causes diarrhea, often with severe or even fatal consequences. As part of its growth cycle, C. diff produces two toxins which cause inflammation and damage the lining of the gut.
"C. diff thrives when other microbes in the gut are absent - which is why it is more prevalent following antibiotic ...
2021-01-19
As the air continues to dry and temperatures drop, the yearly battle against dry hands and skin has officially begun. New research from Northwestern University has found new evidence deep within the skin about the mechanisms controlling skin repair and renewal.
Skin's barrier function gives it the unique ability to fight winter woes and retain water for our bodies. The outer layer of the skin, the epidermis, is constantly turning over to replace dead or damaged cells, creating new cells to reinforce the barrier function and heal damage. The gene regulatory mechanisms that control epidermis turnover remain incompletely understood.
"Every month we're covered with a new layer of epidermis," said Northwestern's Xiaomin Bao, who led the study. "The next question is what does that process ...
2021-01-19
The United States incarcerates more residents than any other country, however there is limited research that examines how people view such punishment, and whether views about punishment change with development. Previous research on this topic raises two very different possibilities: 1) children are typically more optimistic than adults, making them more likely to report that people's moral character improves following punishment, and 2) children are more likely than adults to report that others' characteristics - including moral traits - are unchangeable, making them less likely than adults to report that punishment affects moral growth. Researchers probed these contrasting possibilities further in two studies exploring children's and adults' views about the impact of ...
2021-01-19
During the COVID-19 pandemic, parents have been faced with challenging circumstances to balance work, household, care of children and support of distance learning for school-age children without help from their regular support systems such as schools, childcare, and often other family members as well. A new longitudinal study in Germany examined day-to-day parenting behavior during the restrictions and closures caused by the pandemic from the end of March until the end of April 2020. Research showed that autonomy-supportive parenting (offering meaningful choices when possible) contributed to positive well-being for both children and parents.
The findings were published in a Child Development article ...
2021-01-19
AUGUSTA, Ga. (Jan. 19, 2021) - A look at RNA tells us what our genes are telling our cells to do, and scientists say looking directly at the RNA of brain tumor cells appears to provide objective, efficient evidence to better classify a tumor and the most effective treatments.
Gliomas are the most common brain tumor type in adults, they have a wide range of possible outcomes and three subtypes, from the generally more treatable astrocytomas and oligodendrogliomas to the typically more lethal glioblastomas.
Medical College of Georgia scientists report in the journal Scientific Reports that their method, which produces what is ...
2021-01-19
Philadelphia, January 19, 2021 - Early life experiences can have an outsized effect on brain development and neurobiological health. New research is showing that those effects can be passed down to subsequent generations, reporting that the infant children of mothers who had experienced childhood emotional neglect displayed altered brain circuitry involved in fear responses and anxiety.
The study appears in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier.
"These results show that our brain development is not only shaped by what happens in our own life, ...
2021-01-19
LA JOLLA, CALIF. - Jan 20, 2020 - Scientists have identified two drugs that are potent against acute myeloid leukemia (AML) when combined, but only weakly effective when used alone. The researchers were able to significantly enhance cancer cell death by jointly administering the drugs that are only partially effective when used as single-agent therapies. The study, a collaboration between Sanford Burnham Prebys Medical Discovery Institute and the University of Glasgow, was recently published in the journal Nature Communications.
"Our study shows that two types of drugs, MDM2 inhibitors and BET inhibitors, work synergistically to promote significant anti-leukemia activity," says Peter Adams, Ph.D., a professor at Sanford Burnham Prebys and senior author of the study. "The results ...
2021-01-19
New research has demonstrated that a simple, cheap test can help identify who is at risk of developing colorectal cancer, aiding early diagnosis and potentially saving lives.
Led by the University of Exeter, and supported by the Peninsula and the Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliances, and by the Cancer Research UK CanTest Collaborative, a new study published today in the British Journal of Cancer examined data from nearly 4,000 patients aged 50 and over. The study involved all healthcare providers in the South West of England taking a new approach. ...
2021-01-19
Successive governments' approach to obesity policies has destined them to fail, say researchers.
Government obesity policies in England over the past three decades have largely failed because of problems with implementation, lack of learning from past successes or failures, and a reliance on trying to persuade individuals to change their behaviour rather than tackling unhealthy environments. This is the conclusion of new research by a team at the University of Cambridge funded by the NIHR School for Public Health Research.
The researchers say their findings may help to explain why, after nearly thirty years of government obesity policies, obesity prevalence in England has not fallen and substantial inequalities persist. According to a report by NHS Digital in May 2020, ...
2021-01-19
Young Seychelles warblers fare better if their elderly parents have help raising them, according to new research from the University of East Anglia (UEA) and the University of Groningen.
Seychelles warblers, a cooperatively breeding species of songbird that lives in small family groups, share the care of young between parents and helpers. This collaboration can compensate for a decline in the ability of elderly parents to provide sufficient care, the researchers found. It may also promote more social behaviour in family groups with older parents.
The findings help explain why social species, such as humans, often do better if they live in groups and cooperate to raise offspring.
The ...
LAST 30 PRESS RELEASES:
[Press-News.org] A clinical trial provides encouraging results on ivermectin for reducing mild COVID-19
